sb 203580 has been researched along with mevalonic acid in 2 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (mevalonic acid) | Trials (mevalonic acid) | Recent Studies (post-2010) (mevalonic acid) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 3,810 | 33 | 922 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maruyama, K; Morishita, E; Ohtake, S; Sekiya, A; Torishima, H | 1 |
| Hu, Z; Li, R; Li, Y; Tian, J; Wang, C; Wang, Y; Zhou, X | 1 |
2 other study(ies) available for sb 203580 and mevalonic acid
| Article | Year |
|---|---|
Fluvastatin Upregulates the Expression of Tissue Factor Pathway Inhibitor in Human Umbilical Vein Endothelial Cells.
Topics: Anticoagulants; Antigens; Blotting, Western; Cells, Cultured; Chromones; Dactinomycin; Fatty Acids, Monounsaturated; Fluvastatin; Human Umbilical Vein Endothelial Cells; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imidazoles; Indoles; Lipoproteins; Luciferases; Maleimides; Mevalonic Acid; Morpholines; Pyridines; Real-Time Polymerase Chain Reaction; RNA, Messenger; Up-Regulation | 2015 |
Mitogen-activated protein kinase mediates mevalonate-stimulated human mesangial cell proliferation.
Topics: Anthracenes; Apoptosis; bcl-2-Associated X Protein; Cell Cycle; Cell Line; Cell Proliferation; Collagen Type I; Collagen Type IV; Dose-Response Relationship, Drug; Extracellular Matrix; Flavonoids; Gene Expression Regulation; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Mesangial Cells; Mevalonic Acid; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Pyridines; Signal Transduction; Transforming Growth Factor beta1 | 2015 |